Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fesoterodine fumarate (Toviaz) is the fumarate salt form of fesoterodine, a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. Fesoterodine is rapidly hydrolyzed in vivo into its active metabolite 5-hydroxymethyl tolterodine, which binds and inhibits muscarinic receptors on the bladder detrusor muscle, thereby preventing bladder contractions or spasms caused by acetylcholine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 77.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 155.00 | |
100 mg | In stock | $ 239.00 | |
500 mg | In stock | $ 463.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 55.00 |
Description | Fesoterodine fumarate (Toviaz) is the fumarate salt form of fesoterodine, a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. Fesoterodine is rapidly hydrolyzed in vivo into its active metabolite 5-hydroxymethyl tolterodine, which binds and inhibits muscarinic receptors on the bladder detrusor muscle, thereby preventing bladder contractions or spasms caused by acetylcholine. |
In vitro | Fesoterodine is rapidly and extensively converted to 5-HMT, such that the pharmacologic activity appears to be primarily attributable to 5-HMT. [1] Fesoterodine is a competitive antagonist of cholinergic agonist-stimulated responses in human M1-M5 cell lines and has a similar potency and selectivity profile to the radioligand-binding studies. Fesoterodine causes a rightward shift of the concentration-response curve for carbachol with no depression of the maximum in rat bladder strips, and concentration-dependently reduces contractions induced by electrical field stimulation (EFS). [2] Fesoterodine is hydrolyzed by nonspecific esterases to 5-hydroxmethyl tolterodine (5-HMT), which is the active metabolite and is responsible for all its antimuscarinic activity. [3] |
Synonyms | Toviaz, SPM 907 |
Molecular Weight | 527.65 |
Formula | C26H37NO3·C4H4O4 |
CAS No. | 286930-03-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 93 mg/mL (176.3 mM)
H2O: 92 mg/mL (174.4 mM)
Ethanol: 93 mg/mL (176.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fesoterodine fumarate 286930-03-8 Neuroscience AChR 5-HMT antimuscarinic SPM-907 muscarinic mAChR overactive Fesoterodine Fumarate inhibit OAB Fesoterodine receptor SPM7605 Muscarinic acetylcholine receptor bladder Toviaz SPM 907 Desfesoterodine SPM907 Inhibitor orally inhibitor